GAINESVILLE, FL--(Marketwired - January 14, 2014) - Quick-Med Technologies, Inc. (OTCQB: QMDT) (PINKSHEETS: QMDT), a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today that it has licensed its Stay Fresh
"We are very excited to enter this new product segment of hydrocolloids with a partner that is close to home, manufacturing high quality wound care products for global distribution. Our antimicrobial technology will greatly expand the number of patients we can provide with safe, effective antimicrobial products in support of infection prevention and control programs. Our technologies are specifically designed to be effective against resistant organisms like MRSA, and to prevent new resistant bacteria from emerging" said Bernd Liesenfeld, Quick-Med's President. This is the initial commercial application of Quick-Med's newest Stay Fresh format: an antimicrobial superabsorbent powder (SAP) that can be directly substituted for a conventional SAP to provide strong and durable antimicrobial activity in applications including health care and hygiene.
"Hydrocolloids are excellent at maintaining the correct moisture balance to optimize wound closure and healing," notes Professor Gregory Schultz, Director of the Institute for Wound Research and Professor of Obstetrics and Gynecology at the University of Florida. "Stay Fresh antimicrobial activity is based on peroxide, which is the chemical mechanism utilized by the body's own neutrophils to kill invading pathogens, and therefore provides optimum biological safety."
"Sarasota Medical Products manufactures a broad array of premium quality ostomy and advanced wound care products that will now include Quick-Med's Stay Fresh
Stay Fresh is Quick-Med's newest technology platform. This technology is based on hydrogen peroxide -- a well known consumer antimicrobial product that is commonly used in households for disinfecting cuts, scrapes, toothbrushes and more. Hydrogen peroxide is also produced by human cells to combat invasive bacteria, and is a naturally occurring preservative component of milk and honey. EPA has registered Stay Fresh to be utilized to protect a broad selection of treated goods for consumer use, including textiles, decorative fabrics, and functional fabrics such as filters and carpets. FDA has also granted clearance to market an antibacterial medical textile based on Stay Fresh Technology. The Stay Fresh technology offerings provided by Quick-Med are expanding continuously, with development of additional applications including antimicrobial surface treatments, and superabsorbent antimicrobial powders to complement the range of products that are already cleared for consumer use under EPA or FDA jurisdiction.
About Quick-Med Technologies, Inc.
Quick-Med Technologies, Inc. is a life sciences company that is developing and commercializing proprietary, broad-based technologies for the consumer and healthcare markets. The Company's NIMBUS
About Sarasota Medical Products
Sarasota Medical Products Inc. (SMP) develops and manufactures ostomy and advanced wound care products in Sarasota, FL. SMP has a growing portfolio of proprietary technology to drive next-generation product development in the wound, ostomy and incontinence market segments. SMP specializes in gentle and secure adhesive formulations that are suitable for long or short-term skin wear, and is a leader in developing technologies to deliver medication and active oxygen to chronic wounds. As a contract manufacturer and technology development partner, SMP offers creative, collaborative and custom device design services for medical products. Information: www.sarasotamedical.com
© 2014 Quick-Med Technologies, Inc. All rights reserved. NIMBUS
Forward-looking statements (statements which are not historical facts) in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained in this release that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as "may", "will", "to", "expect", "plan", "believe", "anticipate", "intend", "could", "would", "estimate", and/or "continue" or the negative or other variations thereof or comparable terminology are intended to identify forward-looking statements involve risks and uncertainties, including those risks that are discussed in the Company's filings with the Securities and Exchange Commission ("SEC"), which may be accessed at the SEC's Edgar System at www.sec.gov.